E&S Healthcare Co., Ltd.

E&S Healthcare is a Health Care startup that was founded in 2013. The company's slogan "Pioneering early and accurate cancer diagnosis through advanced blood technology" reflects its innovative approach towards cancer diagnosis. In August 2019, E&S Healthcare secured a significant $7.39M Series B investment from Magellan Technology Investment. This funding is a testament to the company's potential and the confidence that investors have in its advanced blood technology for early cancer detection. E&S Healthcare's focus on leveraging technology for early diagnosis in the healthcare sector positions it as a promising player in the industry, with the potential to make a substantial impact in cancer diagnosis and treatment.